131 related articles for article (PubMed ID: 38659223)
1. Sirt6 protects retinal ganglion cells and optic nerve from degeneration during aging and glaucoma.
Xia F; Shi S; Palacios E; Liu W; Buscho SE; Li J; Huang S; Vizzeri G; Dong XC; Motamedi M; Zhang W; Liu H
Mol Ther; 2024 Jun; 32(6):1760-1778. PubMed ID: 38659223
[TBL] [Abstract][Full Text] [Related]
2. Role of hypoxia-inducible factor-1α in preconditioning-induced protection of retinal ganglion cells in glaucoma.
Zhu Y; Zhang L; Gidday JM
Mol Vis; 2013; 19():2360-72. PubMed ID: 24319330
[TBL] [Abstract][Full Text] [Related]
3. DRP1 inhibition rescues retinal ganglion cells and their axons by preserving mitochondrial integrity in a mouse model of glaucoma.
Kim KY; Perkins GA; Shim MS; Bushong E; Alcasid N; Ju S; Ellisman MH; Weinreb RN; Ju WK
Cell Death Dis; 2015 Aug; 6(8):e1839. PubMed ID: 26247724
[TBL] [Abstract][Full Text] [Related]
4. CNS axonal degeneration and transport deficits at the optic nerve head precede structural and functional loss of retinal ganglion cells in a mouse model of glaucoma.
Maddineni P; Kasetti RB; Patel PD; Millar JC; Kiehlbauch C; Clark AF; Zode GS
Mol Neurodegener; 2020 Aug; 15(1):48. PubMed ID: 32854767
[TBL] [Abstract][Full Text] [Related]
5. The dark phase intraocular pressure elevation and retinal ganglion cell degeneration in a rat model of experimental glaucoma.
Kwong JM; Vo N; Quan A; Nam M; Kyung H; Yu F; Piri N; Caprioli J
Exp Eye Res; 2013 Jul; 112():21-8. PubMed ID: 23603611
[TBL] [Abstract][Full Text] [Related]
6. A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma.
Krishnan A; Kocab AJ; Zacks DN; Marshak-Rothstein A; Gregory-Ksander M
J Neuroinflammation; 2019 Sep; 16(1):184. PubMed ID: 31570110
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal delivery of human NgR-Fc decoy protein regenerates axons after optic nerve crush and protects ganglion cells in glaucoma models.
Wang X; Lin J; Arzeno A; Choi JY; Boccio J; Frieden E; Bhargava A; Maynard G; Tsai JC; Strittmatter SM
Invest Ophthalmol Vis Sci; 2015 Feb; 56(2):1357-66. PubMed ID: 25655801
[TBL] [Abstract][Full Text] [Related]
8. The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma.
Harada T; Harada C; Nakamura K; Quah HM; Okumura A; Namekata K; Saeki T; Aihara M; Yoshida H; Mitani A; Tanaka K
J Clin Invest; 2007 Jul; 117(7):1763-70. PubMed ID: 17607354
[TBL] [Abstract][Full Text] [Related]
9. Targeting HDAC3 in the DBA/2J spontaneous mouse model of glaucoma.
Schmitt HM; Grosser JA; Schlamp CL; Nickells RW
Exp Eye Res; 2020 Nov; 200():108244. PubMed ID: 32971093
[TBL] [Abstract][Full Text] [Related]
10. Enlarged Optic Nerve Axons and Reduced Visual Function in Mice with Defective Microfibrils.
Wu HJ; Hazlewood RJ; Kuchtey J; Kuchtey RW
eNeuro; 2018; 5(5):. PubMed ID: 30406200
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors for Retinal Ganglion Cell Distress in Glaucoma and Neuroprotective Potential Intervention.
Vernazza S; Oddone F; Tirendi S; Bassi AM
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360760
[TBL] [Abstract][Full Text] [Related]
12. Increased bioavailability of cyclic guanylate monophosphate prevents retinal ganglion cell degeneration.
Wareham LK; Dordea AC; Schleifer G; Yao V; Batten A; Fei F; Mertz J; Gregory-Ksander M; Pasquale LR; Buys ES; Sappington RM
Neurobiol Dis; 2019 Jan; 121():65-75. PubMed ID: 30213732
[TBL] [Abstract][Full Text] [Related]
13. Retinal ganglion cell morphology after optic nerve crush and experimental glaucoma.
Kalesnykas G; Oglesby EN; Zack DJ; Cone FE; Steinhart MR; Tian J; Pease ME; Quigley HA
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3847-57. PubMed ID: 22589442
[TBL] [Abstract][Full Text] [Related]
14. Aldosterone: a mediator of retinal ganglion cell death and the potential role in the pathogenesis in normal-tension glaucoma.
Nitta E; Hirooka K; Tenkumo K; Fujita T; Nishiyama A; Nakamura T; Itano T; Shiraga F
Cell Death Dis; 2013 Jul; 4(7):e711. PubMed ID: 23828574
[TBL] [Abstract][Full Text] [Related]
15. Assessment of retinal ganglion cell damage in glaucomatous optic neuropathy: Axon transport, injury and soma loss.
Nuschke AC; Farrell SR; Levesque JM; Chauhan BC
Exp Eye Res; 2015 Dec; 141():111-24. PubMed ID: 26070986
[TBL] [Abstract][Full Text] [Related]
16. Retinal ganglion cell loss in a rat ocular hypertension model is sectorial and involves early optic nerve axon loss.
Soto I; Pease ME; Son JL; Shi X; Quigley HA; Marsh-Armstrong N
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):434-41. PubMed ID: 20811062
[TBL] [Abstract][Full Text] [Related]
17. Under pressure: cellular and molecular responses during glaucoma, a common neurodegeneration with axonopathy.
Nickells RW; Howell GR; Soto I; John SW
Annu Rev Neurosci; 2012; 35():153-79. PubMed ID: 22524788
[TBL] [Abstract][Full Text] [Related]
18. Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma.
Buckingham BP; Inman DM; Lambert W; Oglesby E; Calkins DJ; Steele MR; Vetter ML; Marsh-Armstrong N; Horner PJ
J Neurosci; 2008 Mar; 28(11):2735-44. PubMed ID: 18337403
[TBL] [Abstract][Full Text] [Related]
19. Tau Accumulation, Altered Phosphorylation, and Missorting Promote Neurodegeneration in Glaucoma.
Chiasseu M; Cueva Vargas JL; Destroismaisons L; Vande Velde C; Leclerc N; Di Polo A
J Neurosci; 2016 May; 36(21):5785-98. PubMed ID: 27225768
[TBL] [Abstract][Full Text] [Related]
20. Jnk2 deficiency increases the rate of glaucomatous neurodegeneration in ocular hypertensive DBA/2J mice.
Harder JM; Williams PA; Soto I; Foxworth NE; Fernandes KA; Freeburg NF; Libby RT; John SWM
Cell Death Dis; 2018 Jun; 9(6):705. PubMed ID: 29899326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
